Wisconsin Alumni Research Foundation

Therapeutics & Vaccines
Therapeutics Vaccines
Methods And Pharmaceutical Compositions For Treating Adverse Or Deleterious Sequellae Of Traumatic Brain Injury
WARF: P100307US02

Inventors: Thomas Sutula, Elizabeth Hutchinson, M. Elizabeth Meyerand, Paul Rutecki

The Invention
This invention provides methods for reducing the extent and progression of traumatic brain injury and its deleterious sequellae specifically cognitive decline, post-traumatic epilepsy, post-traumatic stress disorder, and other adverse consequences depending on the progression of the initial injury, comprising administering to a TBI victim in need thereof a therapeutically-effective amount of an antiglycolytic compound, particularly 2-deoxyglucose (2-DG) or glycolysis-inhibiting analogs thereof. The invention also provides pharmaceutical compositions of 2-DG or glycolysis-inhibiting analogs thereof for use in the methods of the invention.
Additional Information
For More Information About the Inventors
For current licensing status, please contact Rafael Diaz at [javascript protected email address] or 608-960-9847